Cargando…
Mortality in Hemodialysis Patients with COVID-19, the Effect of Paricalcitol or Calcimimetics
Background. In COVID-19 patients, low serum vitamin D (VD) levels have been associated with severe acute respiratory failure and poor prognosis. In regular hemodialysis (HD) patients, there is VD deficiency and markedly reduced calcitriol levels, which may predispose them to worse outcomes of COVID-...
Autores principales: | Arenas Jimenez, María Dolores, González-Parra, Emilio, Riera, Marta, Rincón Bello, Abraham, López-Herradón, Ana, Cao, Higini, Hurtado, Sara, Collado, Silvia, Ribera, Laura, Barbosa, Francesc, Dapena, Fabiola, Torregrosa, Vicent, Broseta, José-Jesús, Soto Montañez, Carlos, Navarro-González, Juan F., Ramos, Rosa, Bover, Jordi, Nogués-Solan, Xavier, Crespo, Marta, Dusso, Adriana S., Pascual, Julio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401800/ https://www.ncbi.nlm.nih.gov/pubmed/34444716 http://dx.doi.org/10.3390/nu13082559 |
Ejemplares similares
-
Control of hyperparathyroidism with the intravenous calcimimetic etelcalcetide in dialysis patients adherent and non-adherent to oral calcimimetics
por: Arenas, Maria Dolores, et al.
Publicado: (2020) -
Etelcalcetide and Paricalcitol in Chronic Kidney Disease: When the Target Is Inflammation
por: D’Marco, Luis, et al.
Publicado: (2022) -
Calcimimetics and outcomes in CKD
por: Drüeke, Tilman B
Publicado: (2013) -
Parathyroidectomy Versus Calcimimetic: The Lower the PTH the Better?
por: Evenepoel, Pieter, et al.
Publicado: (2022) -
Chemoenzymatic Approaches to the Synthesis of the Calcimimetic Agent Cinacalcet Employing Transaminases and Ketoreductases
por: Marx, Lisa, et al.
Publicado: (2018)